Amount Raised
$75 Million
Round Type
Post-IPO Equity
SomervilleBiotechnologyHealth CareTherapeuticsDescription
bluebird bio, Inc. (NASDAQ: BLUE) announced today that it has entered into an agreement for a $75 million private placement of common stock and common stock equivalents with a healthcare investment fund selected as part of a competitive process. Proceeds from the financing will support ongoing R&D and commercialization investments for bluebird bio and for 2seventy bio, which plan to launch as independent companies in October 2021. The closing of the private placement is expected to occur in September 2021, subject to the satisfaction of customary closing conditions.
Quick answer
bluebird bio raised $75 Million in a Post-IPO Equity round, dated September 8, 2021. bluebird bio is based in Somerville, Massachusetts, United States.
- How much did bluebird bio raise?
- bluebird bio raised $75 Million in a Post-IPO Equity round on September 8, 2021.
- What does bluebird bio do?
- bluebird bio is a commercial-stage biotherapeutics company focused on developing and delivering gene therapies for severe genetic diseases.
- Where is bluebird bio based and how big is it?
- bluebird bio is based in Somerville, Massachusetts, United States. Fundz records about 449 employees.
- Who are the decision-makers at bluebird bio?
- Fundz holds 1 contact at bluebird bio, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as bluebird bio that raised within 45 days of this round, from Fundz verified event records.
- Chase Therapeutics Corporation raised $20M (Series B) on October 20, 2021.
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised an undisclosed amount (Debt Financing) on October 18, 2021.
- Alpha Cognition raised $425K (Seed) on October 18, 2021.
- MAIA Biotechnology raised $6.2M (Funding Round) on October 14, 2021.
- Amicus Therapeutics raised $200M on October 13, 2021.
- DiaMedica Therapeutics raised $30M on October 6, 2021.
Who to call at bluebird bio, and when
A new round usually means bluebird bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day bluebird bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at bluebird bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at bluebird bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment bluebird bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
bluebird bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.